ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2026, Vol. 35 ›› Issue (2): 195-199.DOI: 10.3969/j.issn.1006⁃298X.2026.02.019

• 临床集锦 • 上一篇    

阿达木单抗治疗大动脉炎合并肾损伤

  

  • 出版日期:2026-04-28 发布日期:2026-04-23

A case of Takayasu arteritis with renal injury treated with adalimumab

  • Online:2026-04-28 Published:2026-04-23

摘要: 青年男性患者,因视物模糊、乏力就诊,检查示高血压急症,蛋白尿 3+, 血清肌酐升高,血沉和 C 反应蛋白高,抗体及补体正常,对症治疗无效,并出现脑梗死伴跛行,进一步检查发现炎症指标持续升高,多发大动脉狭窄,诊断多发性大动脉炎、恶性高血压。给予糖皮质激素、吗替麦考酚酯联合阿达木单抗及降压对症治疗后,血压稳定,跛行改善,炎症指标正常,肾功能好转。

关键词: 多发性大动脉炎, 阿达木单抗, 肾功能不全, 高血压

Abstract: A young male patient presented with blurred vision and fatigue.Examination revealed acute hypertension,proteinuria3+,elevated serum creatinine,increased erythrocyte sedimentation rate (ESR) and C⁃reactive protein (CRP),while antibody and complement levels were normal.Symptomatic treatment was ineffective,and the patient developed cerebral infarction with claudication.Further investigations identified persistently elevated inflammatory markers and multiple large artery stenoses,leading to a diagnosis of takayasu arteritis and malignant hypertension.After treatment with glucocorticoids,mycophenolate mofetil combined with adalimumab and antihypertensive therapy,blood pressure stabilized,claudication improved,inflammatory markers normalized,and renal function recovered.